When was GYNETICS MEDICAL PRODUCTS founded?

GYNETICS MEDICAL PRODUCTS was founded on 27 Sep 1972, making it 53 years old.

Is GYNETICS MEDICAL PRODUCTS still active?

Yes, GYNETICS MEDICAL PRODUCTS is currently active.

Where is GYNETICS MEDICAL PRODUCTS registered?

GYNETICS MEDICAL PRODUCTS's registered address is Rembert Dodoensstraat 51, 3920 Lommel, Belgium.

How many employees does GYNETICS MEDICAL PRODUCTS have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), GYNETICS MEDICAL PRODUCTS reported 4.2 full-time equivalent employees.

What is GYNETICS MEDICAL PRODUCTS's annual turnover?

GYNETICS MEDICAL PRODUCTS's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €4,515,789.

Did GYNETICS MEDICAL PRODUCTS make a profit or a loss?

GYNETICS MEDICAL PRODUCTS's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €1,345,682.

When did GYNETICS MEDICAL PRODUCTS last file annual accounts?

GYNETICS MEDICAL PRODUCTS's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is GYNETICS MEDICAL PRODUCTS B Corp certified?

We have no B Corp certification on file for GYNETICS MEDICAL PRODUCTS.

Does GYNETICS MEDICAL PRODUCTS hold Fairtrade certification?

No, GYNETICS MEDICAL PRODUCTS does not currently hold Fairtrade certification.

GYNETICS MEDICAL PRODUCTS

Q: What does GYNETICS MEDICAL PRODUCTS do?

GYNETICS MEDICAL PRODUCTS's registered main activities are Wholesale of pharmaceutical and medical goods, Wholesale of other machinery and equipment n.e.c., Manufacture of ovens, furnaces and permanent household heating equipment, Manufacture of electro diagnostic devices, such as electro radiographic devices, ultrasonic diagnostic apparatus, CT scintillation nuclear magnetic resonance installations,, and Wholesale trade of medical, surgical and dental supplies.

BE 0412.701.841

Copied!

NV/SA

Status

Active

Founded

27 Sep 1972 · 53 yrs

Size

Small · 4.2 FTE

Abbreviation

G.M.P.

Main activity

Wholesale of pharmaceutical and medical goods

Website

gynetics.be

Activities

5 activities

Wholesale of pharmaceutical and medical goodsWholesale of other machinery and equipment n.e.c.Manufacture of ovens, furnaces and permanent household heating equipmentManufacture of electro diagnostic devices, such as electro radiographic devices, ultrasonic diagnostic apparatus, CT scintillation nuclear magnetic resonance installations,Wholesale trade of medical, surgical and dental supplies

Financials

Turnover2025

€4.5M-17.8%

Profit / Loss2025

€1.3M-29.1%

Equity2025

€4.8M+38.6%

2025	2024	2023	2022
€4,515,789-17.8%	€5,496,422+17.2%	€4,689,051	—
€1,345,682-29.1%	€1,897,633+12.6%	€1,685,691-7.8%	€1,827,487
€4,829,997+38.6%	€3,484,314+119.6%	€1,586,682+88.9%	€839,951
€511,749-17.9%	€623,007-6.7%	€667,709-78.7%	€3,140,997
€1,315,173+92.8%	€682,059+18%	€578,215-51%	€1,179,007
4.2-12.5%	4.8-2%	4.9-2%	5
€1,075,188-6.1%	€1,145,088+19.7%	€956,949	—

Frequently asked questions

01What is GYNETICS MEDICAL PRODUCTS's official registered name?

GYNETICS MEDICAL PRODUCTS.

02What is GYNETICS MEDICAL PRODUCTS's enterprise number (VAT number)?

BE 0412.701.841.

03What is GYNETICS MEDICAL PRODUCTS's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€4,515,789-17.8%	€5,496,422+17.2%	€4,689,051	—
	—	—	—	€2,992,104
	€432,904+10%	€393,571+9.6%	€359,161+9.7%	€327,283
	—	—	—	€3,433
	€1,802,225-29.3%	€2,549,481+11.4%	€2,289,224-8.7%	€2,506,184
	€1,832,151-27.5%	€2,525,896+12.8%	€2,239,522-13.9%	€2,601,206
	€1,345,682-29.1%	€1,897,633+12.6%	€1,685,691-7.8%	€1,827,487
	€29,683-10.8%	€33,290+186.2%	€11,631-98.8%	€1,005,419
Profitability
	40.6%-11.7%	46.0%-3.8%	47.8%	—
	29.8%-13.7%	34.5%-4%	35.9%	—
	27.9%-48.8%	54.5%-48.7%	106.2%-51.2%	217.6%
	25.2%-45.5%	46.2%-38.2%	74.8%+62.9%	45.9%
Solvency
	€5,341,745+30.1%	€4,107,322+82.2%	€2,254,391-43.4%	€3,980,948
	€107,064+4.1%	€102,813+406.3%	€20,305-95.2%	€421,845
	€1,180,3840%	€1,180,384>1000%	€11,700>1000%	€248
	€4,829,997+38.6%	€3,484,314+119.6%	€1,586,682+88.9%	€839,951
	90.4%+6.6%	84.8%+20.5%	70.4%+233.6%	21.1%
	€215,880+89.3%	€114,027-52.5%	€240,000	—
	0.04+36.6%	0.03-78.4%	0.15	—
	€511,749-17.9%	€623,007-6.7%	€667,709-78.7%	€3,140,997
	0.11-40.7%	0.18-57.5%	0.42-88.7%	3.74
	—	19317.18	—	—
Liquidity
	€1,315,173+92.8%	€682,059+18%	€578,215-51%	€1,179,007
	€2,177,460+37.7%	€1,581,717+53.7%	€1,029,039-5%	€1,083,557
	€435,664+10.7%	€393,649-3.6%	€408,373-40.6%	€687,581
	€224,742-34.7%	€344,280-0.9%	€347,449+17.1%	€296,806
	€295,869-41.9%	€508,980+19%	€427,709-86.4%	€3,140,997
	9.26+120%	4.21+9.5%	3.84+407.4%	0.76
	€3,758,429+62.3%	€2,315,145+29%	€1,794,677+329.5%	€417,858
Efficiency
	35 days+34.7%	26 days-17.8%	32 days	—
	29 days-30.9%	42 days-15.6%	50 days	—
	338 days+41.6%	238 days+39.7%	171 days	—
	1.25-32.8%	1.86-10.6%	2.08	—
Profit appropriation
	—	€0-100%	€900,000-50%	€1,800,000
	€4,689,437+40.2%	€3,343,754+131.2%	€1,446,122+106.8%	€699,391

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€4,515,789-17.8%	€5,496,422+17.2%	€4,689,051	—
	—	—	—	€2,992,104
	€432,904+10%	€393,571+9.6%	€359,161+9.7%	€327,283
	—	—	—	€3,433
	€1,802,225-29.3%	€2,549,481+11.4%	€2,289,224-8.7%	€2,506,184
	€1,832,151-27.5%	€2,525,896+12.8%	€2,239,522-13.9%	€2,601,206
	€1,345,682-29.1%	€1,897,633+12.6%	€1,685,691-7.8%	€1,827,487
	€29,683-10.8%	€33,290+186.2%	€11,631-98.8%	€1,005,419
Profitability
	40.6%-11.7%	46.0%-3.8%	47.8%	—
	29.8%-13.7%	34.5%-4%	35.9%	—
	27.9%-48.8%	54.5%-48.7%	106.2%-51.2%	217.6%
	25.2%-45.5%	46.2%-38.2%	74.8%+62.9%	45.9%
Solvency
	€5,341,745+30.1%	€4,107,322+82.2%	€2,254,391-43.4%	€3,980,948
	€107,064+4.1%	€102,813+406.3%	€20,305-95.2%	€421,845
	€1,180,3840%	€1,180,384>1000%	€11,700>1000%	€248
	€4,829,997+38.6%	€3,484,314+119.6%	€1,586,682+88.9%	€839,951
	90.4%+6.6%	84.8%+20.5%	70.4%+233.6%	21.1%
	€215,880+89.3%	€114,027-52.5%	€240,000	—
	0.04+36.6%	0.03-78.4%	0.15	—
	€511,749-17.9%	€623,007-6.7%	€667,709-78.7%	€3,140,997
	0.11-40.7%	0.18-57.5%	0.42-88.7%	3.74
	—	19317.18	—	—
Liquidity
	€1,315,173+92.8%	€682,059+18%	€578,215-51%	€1,179,007
	€2,177,460+37.7%	€1,581,717+53.7%	€1,029,039-5%	€1,083,557
	€435,664+10.7%	€393,649-3.6%	€408,373-40.6%	€687,581
	€224,742-34.7%	€344,280-0.9%	€347,449+17.1%	€296,806
	€295,869-41.9%	€508,980+19%	€427,709-86.4%	€3,140,997
	9.26+120%	4.21+9.5%	3.84+407.4%	0.76
	€3,758,429+62.3%	€2,315,145+29%	€1,794,677+329.5%	€417,858
Efficiency
	35 days+34.7%	26 days-17.8%	32 days	—
	29 days-30.9%	42 days-15.6%	50 days	—
	338 days+41.6%	238 days+39.7%	171 days	—
	1.25-32.8%	1.86-10.6%	2.08	—
Profit appropriation
	—	€0-100%	€900,000-50%	€1,800,000
	€4,689,437+40.2%	€3,343,754+131.2%	€1,446,122+106.8%	€699,391

2025

2024

2023

2022

Income statement

€4,515,789-17.8%

€5,496,422+17.2%

€4,689,051

—

€2,992,104

€432,904+10%

€393,571+9.6%

€359,161+9.7%

€327,283

—

€3,433

€1,802,225-29.3%

€2,549,481+11.4%

€2,289,224-8.7%

€2,506,184

€1,832,151-27.5%

€2,525,896+12.8%

€2,239,522-13.9%

€2,601,206

€1,345,682-29.1%

€1,897,633+12.6%

€1,685,691-7.8%

€1,827,487

€29,683-10.8%

€33,290+186.2%

€11,631-98.8%

€1,005,419

Profitability

40.6%-11.7%

46.0%-3.8%

47.8%

—

29.8%-13.7%

34.5%-4%

35.9%

—

27.9%-48.8%

54.5%-48.7%

106.2%-51.2%

217.6%

25.2%-45.5%

46.2%-38.2%

74.8%+62.9%

45.9%

Solvency

€5,341,745+30.1%

€4,107,322+82.2%

€2,254,391-43.4%

€3,980,948

€107,064+4.1%

€102,813+406.3%

€20,305-95.2%

€421,845

€1,180,3840%

€1,180,384>1000%

€11,700>1000%

€248

€4,829,997+38.6%

€3,484,314+119.6%

€1,586,682+88.9%

€839,951

90.4%+6.6%

84.8%+20.5%

70.4%+233.6%

21.1%

€215,880+89.3%

€114,027-52.5%

€240,000

—

0.04+36.6%

0.03-78.4%

0.15

—

€511,749-17.9%

€623,007-6.7%

€667,709-78.7%

€3,140,997

0.11-40.7%

0.18-57.5%

0.42-88.7%

3.74

—

19317.18

—

Liquidity

€1,315,173+92.8%

€682,059+18%

€578,215-51%

€1,179,007

€2,177,460+37.7%

€1,581,717+53.7%

€1,029,039-5%

€1,083,557

€435,664+10.7%

€393,649-3.6%

€408,373-40.6%

€687,581

€224,742-34.7%

€344,280-0.9%

€347,449+17.1%

€296,806

€295,869-41.9%

€508,980+19%

€427,709-86.4%

€3,140,997

9.26+120%

4.21+9.5%

3.84+407.4%

0.76

€3,758,429+62.3%

€2,315,145+29%

€1,794,677+329.5%

€417,858

Efficiency

35 days+34.7%

26 days-17.8%

32 days

—

29 days-30.9%

42 days-15.6%

50 days

—

338 days+41.6%

238 days+39.7%

171 days

—

1.25-32.8%

1.86-10.6%

2.08

—

Profit appropriation

—

€0-100%

€900,000-50%

€1,800,000

€4,689,437+40.2%

€3,343,754+131.2%

€1,446,122+106.8%

€699,391

GYNETICS MEDICAL PRODUCTS

Activities

Financials

Frequently asked questions

All locations

All locations